272 related articles for article (PubMed ID: 23583636)
1. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests.
Chan KH; Chan JF; Tse H; Chen H; Lau CC; Cai JP; Tsang AK; Xiao X; To KK; Lau SK; Woo PC; Zheng BJ; Wang M; Yuen KY
J Infect; 2013 Aug; 67(2):130-40. PubMed ID: 23583636
[TBL] [Abstract][Full Text] [Related]
2. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5.
Woo PC; Lau SK; Li KS; Tsang AK; Yuen KY
Emerg Microbes Infect; 2012 Nov; 1(11):e35. PubMed ID: 26038405
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.
van Boheemen S; de Graaf M; Lauber C; Bestebroer TM; Raj VS; Zaki AM; Osterhaus AD; Haagmans BL; Gorbalenya AE; Snijder EJ; Fouchier RA
mBio; 2012 Nov; 3(6):. PubMed ID: 23170002
[TBL] [Abstract][Full Text] [Related]
4. Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC.
Du L; Ma C; Jiang S
J Infect; 2013 Oct; 67(4):348-50. PubMed ID: 23685240
[No Abstract] [Full Text] [Related]
5. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
[TBL] [Abstract][Full Text] [Related]
6. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential.
Kindler E; Jónsdóttir HR; Muth D; Hamming OJ; Hartmann R; Rodriguez R; Geffers R; Fouchier RA; Drosten C; Müller MA; Dijkman R; Thiel V
mBio; 2013 Feb; 4(1):e00611-12. PubMed ID: 23422412
[TBL] [Abstract][Full Text] [Related]
7. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.
Müller MA; Raj VS; Muth D; Meyer B; Kallies S; Smits SL; Wollny R; Bestebroer TM; Specht S; Suliman T; Zimmermann K; Binger T; Eckerle I; Tschapka M; Zaki AM; Osterhaus AD; Fouchier RA; Haagmans BL; Drosten C
mBio; 2012 Dec; 3(6):. PubMed ID: 23232719
[TBL] [Abstract][Full Text] [Related]
8. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2020; 11():607918. PubMed ID: 33424856
[TBL] [Abstract][Full Text] [Related]
9. A serological survey on neutralizing antibody titer of SARS convalescent sera.
Zhang JS; Chen JT; Liu YX; Zhang ZS; Gao H; Liu Y; Wang X; Ning Y; Liu YF; Gao Q; Xu JG; Qin C; Dong XP; Yin WD
J Med Virol; 2005 Oct; 77(2):147-50. PubMed ID: 16121363
[TBL] [Abstract][Full Text] [Related]
10. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.
Gierer S; Bertram S; Kaup F; Wrensch F; Heurich A; Krämer-Kühl A; Welsch K; Winkler M; Meyer B; Drosten C; Dittmer U; von Hahn T; Simmons G; Hofmann H; Pöhlmann S
J Virol; 2013 May; 87(10):5502-11. PubMed ID: 23468491
[TBL] [Abstract][Full Text] [Related]
11. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
Front Immunol; 2022; 13():836449. PubMed ID: 35401521
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
[TBL] [Abstract][Full Text] [Related]
13. The emerging novel Middle East respiratory syndrome coronavirus: the "knowns" and "unknowns".
Chan JF; Lau SK; Woo PC
J Formos Med Assoc; 2013 Jul; 112(7):372-81. PubMed ID: 23883791
[TBL] [Abstract][Full Text] [Related]
14. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
Woudenberg T; Pelleau S; Anna F; Attia M; Donnadieu F; Gravet A; Lohmann C; Seraphin H; Guiheneuf R; Delamare C; Stefic K; Marlet J; Brochot E; Castelain S; Augereau O; Sibilia J; Dubos F; Meddour D; Guen CG; Coste-Burel M; Imbert-Marcille BM; Chauvire-Drouard A; Schweitzer C; Gatin A; Lomazzi S; Joulié A; Haas H; Cantais A; Bertholon F; Chinazzo-Vigouroux MF; Abdallah MS; Arowas L; Charneau P; Hoen B; Demeret C; Werf SV; Fontanet A; White M
EBioMedicine; 2021 Aug; 70():103495. PubMed ID: 34304047
[TBL] [Abstract][Full Text] [Related]
15. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
Chan JF; Li KS; To KK; Cheng VC; Chen H; Yuen KY
J Infect; 2012 Dec; 65(6):477-89. PubMed ID: 23072791
[TBL] [Abstract][Full Text] [Related]
16. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.
Chan KH; Cheng VC; Woo PC; Lau SK; Poon LL; Guan Y; Seto WH; Yuen KY; Peiris JS
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1317-21. PubMed ID: 16275947
[TBL] [Abstract][Full Text] [Related]
17. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.
Josset L; Menachery VD; Gralinski LE; Agnihothram S; Sova P; Carter VS; Yount BL; Graham RL; Baric RS; Katze MG
mBio; 2013 Apr; 4(3):e00165-13. PubMed ID: 23631916
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia.
Lynch SA; Subbarao K; Mahanty S; Barber BE; Roulis EV; van der Hoek L; McCarthy JS; Spann KM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452482
[TBL] [Abstract][Full Text] [Related]
20. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.
Temperton NJ; Chan PK; Simmons G; Zambon MC; Tedder RS; Takeuchi Y; Weiss RA
Emerg Infect Dis; 2005 Mar; 11(3):411-6. PubMed ID: 15757556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
